Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Becton Dickinson (NY:BDX)

195.96 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Becton Dickinson

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Looking Into Becton Dickinson's Recent Short Interest
 
Via Benzinga
BDX Q3 Deep Dive: Margin Expansion and Portfolio Moves Drive Positive Market Response
Medical technology company Becton, Dickinson and Company (NYSE:BDX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.9% year on year to $5.51 billion. The company’s outlook for the... 
Via StockStory
Topics World Trade
5 Analysts Have This To Say About Becton Dickinson
 
Via Benzinga
Stay informed with the top movers within the S&P500 index on Thursday.
Let's delve into the developments on the US markets one hour before the close of the markets on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Earnings Scheduled For August 7, 2025
 
Via Benzinga
BD (NYSE:BDX) Reports Q2 In Line With Expectations, Stock Soars
Medical technology company Becton, Dickinson and Company (NYSE:BDX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.9% year on year to $5.51 billion. The company’s outlook for the... 
Via StockStory
Apple Jumps, Eli Lilly Crashes On Worst Day In 25 Years: What's Moving Markets Thursday?
U.S. equities slipped midday Thursday as corporate earnings and fresh tariff announcements from President Donald Trump drove divergent moves in heavyweight names. 
Via Benzinga
Topics Government World Trade
Upcoming Earnings Calls This Week: August 4th - August 10th, 2025
This week, from August 4th to August 10th, 2025, marks a busy period in the second-quarter earnings season, with hundreds of companies across various sectors scheduled to report their financial... 
Via MarketMinute
Topics Artificial Intelligence Economy
Exploring the top movers within the S&P500 index during today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Becton Dickinson Q3 Beats Estimates On Medical Device Boom
Becton Dickinson beat Q3 earnings and revenue estimates, raised its FY25 EPS outlook, and saw strong growth in its medical and interventional segments. 
Via Benzinga
Applovin, Sunrun, Duolingo, Tutor Perini, Installed Building Products And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Thursday's session: gap up and gap down stock in the S&P500 index
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
Via Chartmill
These S&P500 stocks are moving in today's pre-market session
Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday? 
Via Chartmill
BECTON DICKINSON AND CO (NYSE:BDX) Reports Mixed Q3 2025 Earnings with Revenue Slightly Below Estimates but EPS Beat
Becton Dickinson (BDX) reported mixed Q3 2025 earnings, with revenue of $5.509B (+10.4% YoY) slightly missing estimates, while adjusted EPS of $3.68 beat forecasts. Stock rose 5.56% pre-market. 
Via Chartmill
What To Expect From BD’s (BDX) Q2 Earnings
Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be reporting earnings this Thursday before the bell. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence Government World Trade
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
Via The Motley Fool
1 Safe-and-Steady Stock to Own for Decades and 2 Facing Challenges
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US
AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and metabolic drugs. 
Via Benzinga
Topics Government
1 Value Stock with Promising Prospects and 2 Facing Headwinds
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
Schlumberger, Stellantis And ASML Holding Are Among Top 10 Large Cap Losers Last Week (July 14-July 18): Are The Others In Your Portfolio?
Elevance Health and Waters led the weekly large-cap losers, hit by weak earnings, lowered guidance, and analyst downgrades. 
Via Benzinga
The Smartest Dividend Stock to Buy With $1,000 Right Now
Via The Motley Fool
How Do Investors Really Feel About Becton Dickinson?
 
Via Benzinga
Market Monitor News July 15 BMO (Crypto stocks UP - Waters DOWN)
Calm Before the Storm? Wall Street Holds Its Breath Ahead of Earnings and Inflation Bombshells 
Via Chartmill
Topics Economy
Q1 Rundown: BD (NYSE:BDX) Vs Other Surgical Equipment & Consumables - Diversified Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared... 
Via StockStory
Topics Artificial Intelligence Economy
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Monogram Technologies Inc. (Nasdaq - MGRM), Veritex Holdings, Inc. (Nasdaq - VBTX), ESSA Pharma Inc. (Nasdaq - EPIX), Waters Corporation (NYSE - WAT)
From Brodsky & Smith LLC
Via GlobeNewswire
Becton's Biosciences And Diagnostics Arm Slated To Join Waters In $17.5 Billion Merger
BD to spin off its diagnostics and biosciences business in a $17.5 billion merger with Waters, targeting $345 million in synergies by 2030. 
Via Benzinga
1 Large-Cap Stock Worth Investigating and 2 to Think Twice About
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for... 
Via StockStory
The Best High Yield Medical Device Stock to Invest $1,000 in Right Now
Via The Motley Fool
3 of Wall Street’s Favorite Stocks with Mounting Challenges
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
1 Cash-Producing Stock Worth Your Attention and 2 to Brush Off
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.